These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2241106)

  • 1. Factors in prostate cancer metastasis.
    Geldof AA; Rao BR
    Anticancer Res; 1990; 10(5A):1303-6. PubMed ID: 2241106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin treatment increases metastasis of prostate tumor (R3327-MatLyLu).
    Geldof AA; Rao BR
    Anticancer Res; 1988; 8(6):1335-9. PubMed ID: 3218966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat model.
    Geldof AA; van den Tillaar PL; Newling DW; Teule GJ
    Urology; 1997 May; 49(5):795-801. PubMed ID: 9145995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
    Achbarou A; Kaiser S; Tremblay G; Ste-Marie LG; Brodt P; Goltzman D; Rabbani SA
    Cancer Res; 1994 May; 54(9):2372-7. PubMed ID: 8162583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
    Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
    Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
    Li L; Yang G; Ebara S; Satoh T; Nasu Y; Timme TL; Ren C; Wang J; Tahir SA; Thompson TC
    Cancer Res; 2001 Jun; 61(11):4386-92. PubMed ID: 11389065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis-enhancing effect of heparin and its relationship to a lipoprotein factor.
    Chan SY; Pollard M
    J Natl Cancer Inst; 1980 May; 64(5):1121-5. PubMed ID: 6929014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis of prostate tumor cells to bronchus associated lymphoid tissue.
    Geldof AA; Rao BR
    In Vivo; 1989; 3(2):87-91. PubMed ID: 2485140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
    Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
    Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metastatic spread of kidney and prostate cancers in man.
    Viadana E; Bross ID; Pickren JW
    Neoplasma; 1976; 23(3):323-32. PubMed ID: 958534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of high-intensity focused ultrasound on the development of metastases.
    Oosterhof GO; Cornel EB; Smits GA; Debruyne FM; Schalken JA
    Eur Urol; 1997; 32(1):91-5. PubMed ID: 9266238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.